Enhanced inhibition of Avian leukosis virus subgroup J replication by multi-target miRNAs

被引:10
作者
Meng, Qing-Wen [1 ]
Zhang, Zai-Ping [1 ]
Wang, Wei [1 ]
Tian, Jin [1 ]
Xiao, Zhi-Guang [1 ]
机构
[1] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin 150001, Peoples R China
关键词
ALV; miRNA; Inhibition; Gag; Multi-target series; HUMAN-PAPILLOMAVIRUS TYPES; CERVICAL-CANCER; WOMEN; CLASSIFICATION; GUIDELINES; MANAGEMENT;
D O I
10.1186/1743-422X-8-556
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Avian leukosis virus (ALV) is a major infectious disease that impacts the poultry industry worldwide. Despite intensive efforts, no effective vaccine has been developed against ALV because of mutations that lead to resistant forms. Therefore, there is a dire need to develop antiviral agents for the treatment of ALV infections and RNA interference (RNAi) is considered an effective antiviral strategy. Results: In this study, the avian leukosis virus subgroup J (ALV-J) proviral genome, including the gag genes, were treated as targets for RNAi. Four pairs of miRNA sequences were designed and synthesized that targeted different regions of the gag gene. The screened target (i.e., the gag genes) was shown to effectively suppress the replication of ALV-J by 19.0-77.3%. To avoid the generation of escape variants during virus infection, expression vectors of multi-target miRNAs were constructed using the multi-target serial strategy (against different regions of the gag, pol, and env genes). Multi-target miRNAs were shown to play a synergistic role in the inhibition of ALV-J replication, with an inhibition efficiency of viral replication ranging from 85.0-91.2%. Conclusion: The strategy of multi-target miRNAs might be an effective method for inhibiting ALV replication and the acquisition of resistant mutations.
引用
收藏
页数:22
相关论文
共 25 条
  • [1] [Anonymous], 2010, GLOBOCAN 2008 CANC I
  • [2] Cervical cancer screening policies and coverage in Europe
    Anttila, Ahti
    von Karsa, Lawrence
    Aasmaa, Auni
    Fender, Muriel
    Patnick, Julietta
    Rebolj, Matejka
    Nicula, Florian
    Vass, Laszlo
    Valerianova, Zdravka
    Voti, Lydia
    Sauvaget, Catherine
    Ronco, Guglielmo
    [J]. EUROPEAN JOURNAL OF CANCER, 2009, 45 (15) : 2649 - 2658
  • [3] Description of the national situation of cervical cancer screening in the member states of the European Union
    Anttila, Ahti
    Ronco, Guglielmo
    [J]. EUROPEAN JOURNAL OF CANCER, 2009, 45 (15) : 2685 - 2708
  • [4] Apostol I, 2010, TUMORI J, V96, P545
  • [5] Arbyn M, 2007, COLLEGIUM ANTROPOL, V31, P7
  • [6] Trends in cervical cancer incidence and mortality in Bulgaria, Estonia, Latvia, Lithuania and Romania
    Arbyn, Marc
    Antoine, Jerome
    Valerianova, Zdravka
    Maegi, Margit
    Stengrevics, Aivars
    Smailyte, Giedre
    Suteu, Ofelia
    Micheli, Andrea
    [J]. TUMORI JOURNAL, 2010, 96 (04): : 517 - 523
  • [7] Badulescu F, 2011, ROM J MORPHOL EMBRYO, V52, P45
  • [8] The epidemiology of human papillomavirus infection and its association with cervical cancer
    Bosch, F. Xavier
    Qiao, You-Lin
    Castellsague, Xavier
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2006, 94 : S8 - S21
  • [9] Bosoteanu M, 2011, ROM J MORPHOL EMBRYO, V52, P297
  • [10] Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population
    Cuschieri, KS
    Cubie, HA
    Whitley, MW
    Seagar, AL
    Arends, MJ
    Moore, C
    Gilkisson, G
    McGoogan, E
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2004, 57 (01) : 68 - 72